Showing results (151-160 of 288) with videos related to
Sort By:
Pageof 29
JACC. Cardiovascular Interventions|January 23, 2017
5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial ProgramRobert W Yeh, Sigmund Silber, Lianglong Chen, et al.JACC. Cardiovascular Interventions|January 15, 2011
Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stentsLaura Mauri, Joseph M Massaro, Songtao Jiang, et al.Journal of Virology|September 15, 2007
N-glycolyl GM1 ganglioside as a receptor for simian virus 40Maria A Campanero-Rhodes, Alicia Smith, Wengang Chai, et al.American Heart Journal|April 7, 2019
Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) StudyJordan B Strom, Hector Tamez, Yuansong Zhao, et al.Glycoconjugate Journal|June 3, 2025
GM1 oligosaccharide-mediated rescue in GBA-linked Parkinson's disease via modulation of lysosomal and mitochondrial dysfunctionsGiulia Lunghi, Carola Pedroli, Ilaria Tagliabue, et al.Circulation|September 1, 2016
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy StudyCharles D Resor, Ashwin Nathan, Dean J Kereiakes, et al.JACC. Cardiovascular Interventions|August 23, 2014
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trialSammy Elmariah, Anthony J Furlan, Mark Reisman, et al.Journal of the American Society of Hypertension : JASH|May 17, 2015
Renal denervation therapy for hypertension: pathways for moving development forwardWilliam B White, Zorina S Galis, Jeffrey Henegar, et al.JACC. Cardiovascular Interventions|May 26, 2009
3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trialDavid R Holmes, Paul S Teirstein, Lowell Satler, et al.The New England Journal of Medicine|March 16, 2012
Closure or medical therapy for cryptogenic stroke with patent foramen ovaleAnthony J Furlan, Mark Reisman, Joseph Massaro, et al.Pageof 29